Smartee Unveils Clinical Innovations for Mandibular Repositioning at EAS 2026

Smartee's Innovative Steps in Orthodontics

On April 16-18, 2026, the European Aligner Society (EAS) held its 7th congress at the SQUARE – Brussels Convention Centre, celebrating a decade of advancements in orthodontics. This year’s theme, “Aligner Next Generation,” attracted over 1,000 professionals from 65 countries, illustrating a robust interest in the future of orthodontic technology.

Smartee Denti-Technology, a global leader in transparent braces, took center stage to unveil its latest clinical innovations, particularly in mandibular repositioning. The company’s efforts focused on integrating advanced technologies into clinical practices, which aligns perfectly with the congress's emphasis on digital workflows and the incorporation of AI-driven treatment planning.

Key Presentations and Techniques

The congress featured two significant sessions led by Smartee’s orthodontic team. On April 17, Dr. Te Wang, who is affiliated with Prof. Gang Shen's team at Shanghai TaiKang Dental Hospital, delivered an insightful presentation on the S8-SGTB orthodontic system. This innovative approach utilizes the Mandibular Anterior Repositioning Technology (MART) to effectively correct severe Class II skeletal discrepancies.

Dr. Wang's presentation set the tone for a discussion about tackling complex orthodontic challenges, emphasizing not just treatment outcomes but the patient journey as well. Another notable session on April 16 featured Dr. Vélez Lagunes, who discussed early interception and correction of malocclusions in growing patients, highlighting Smartee's clear aligner's unique capabilities in managing growth patterns to mitigate the need for invasive treatments later on.

Following Dr. Vélez’s insights, Dr. Thomas Felkai showcased clinical cases where Smartee technologies, including the S11 Palate Expander, were effectively integrated into treatment protocols for optimal patient outcomes. The enthusiasm was palpable, with numerous practitioners posing detailed inquiries about the biomechanical principles behind mandibular advancements and how to implement the innovations in their practices.

Expanding European Infrastructure

Recognized as a rapidly growing market for clear aligners, Europe presents both challenges and opportunities for Smartee. The company has made significant investments to enhance its regional infrastructure. In 2024, they established a state-of-the-art manufacturing facility in Madrid, serving as a key hub for localized production and delivery across the continent.

Moreover, Smartee furthered its European presence by launching a subsidiary in the UK and creating the European Orthodontic Clinical Support Center in Stoke-on-Trent in October 2025. This center aims to provide treatment planning services, case analyses, and technical assistance compliant with European clinical standards.

To ensure continuous professional development remains relevant and localized, Smartee is actively collaborating with regional opinion leaders and educators. They are dedicated to designing training programs that cater to the specific clinical needs of European orthodontists, reinforcing their commitment to excellence in patient care.

Conclusion

Smartee's participation at the EAS Congress 2026 not only highlighted their groundbreaking innovations in clear aligner technology but also established their role as a pivotal player in the European orthodontic landscape. As they continue to expand their infrastructure and engage with local practitioners, Smartee is poised to redefine the standards of orthodontic treatment and patient outcomes.

With a vision of advancing dental practices through technology and education, Smartee underscores the importance of clinical innovation as the industry moves towards a future where orthodontic care is smarter, more effective, and accessible to all.